<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE To assess the relative contribution of increased fasting and postload plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations to the incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in subjects with a <z:mpath ids='MPATH_458'>normal</z:mpath> 2-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS A total of 3,450 subjects with 2-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration &lt;140 mg/dl at baseline were followed up in the San Antonio Heart Study (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SAHS</z:e>) and the Botnia Study for 7-8 years </plain></SENT>
<SENT sid="2" pm="."><plain>The incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> at follow-up was related to the fasting, 1-h, and 2-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS In subjects with 2-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> &lt;140 mg/dl, the incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> increased with increasing fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (FPG) and 1-h and 2-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations </plain></SENT>
<SENT sid="4" pm="."><plain>In a multivariate logistic analysis, after adjustment for <z:hpo ids='HP_0000001'>all</z:hpo> <z:mp ids='MP_0002055'>diabetes</z:mp> risk factors, the FPG concentration was a strong predictor of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in both the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SAHS</z:e> and the Botnia Study (P &lt; 0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>However, when the 1-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, but not 2-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, concentration was added to the model, FPG concentration was no longer a significant predictor of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in both studies (NS) </plain></SENT>
<SENT sid="6" pm="."><plain>When subjects were matched for the level of 1-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration, the incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> markedly increased with the increase in 1-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, but the increase in FPG was not associated with a significant increase in the incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS An increase in postload glycemia in the <z:mpath ids='MPATH_458'>normal</z:mpath> range is associated with an increase in the incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>After controlling for 1-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration, the increase in FPG concentration is not associated with an increase in the incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>